Tokyo Joe's Cafe / Societe Anonyme/No Pennies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Panita who wrote (87909)	8/5/1999 8:57:00 AM
From: Ron	Read Replies (2) of 119973

DITI FDA news hits the wires: dailynews.yahoo.com WASHINGTON (AP) - A newly approved drug that can literally light up cancerous cells promises help for patients with suspicious chest X-rays who are trying to determine whether they need a biopsy for lung cancer. Diatide Inc.'s (Nasdaq:DITI - news) NeoTect will not replace biopsies in which lung tissue is surgically removed to definitively diagnose cancer. But because NeoTect works differently than other noninvasive cancer tests, ''it is a very valuable tool'' for deciding which patients need a biopsy, said Dr. Florence Houn of the Food and Drug Administration. NeoTect, approved Wednesday, is for patients whose chest X-rays or CT scans show a mass that doctors cannot determine is benign or cancerous. Sometimes mere scars, for instance, appear suspicious. Many types of lung cancer produce a protein called somatostatin. NeoTect is injected into the arm and travels to the lungs, where it detects somatostatin by latching onto somatostatin ''receptors,'' or docking points, on cancer cells. NeoTect carries a radioactive label that lights up the cancer under a common nuclear-medicine camera.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next